Table 3 Annual coverage and sustainability estimated for Farmácia Popular Program, (FP, PMAQ, PNAUM,VIGITEL,PNS), Brazil 2007 to 2015
Year | Prevalencea | Coverage (%) | Total MoH expenditures on medicines (in Millions of reais)h | Estimated Expenditure to cover all people by Farmácia Popular (as a percentage of total MoH expenditures on medicines) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FP_Cov_1b | FP_Cov_2c | PMAQd | PNAUMe | VIGITELf | PNSg | FP_Cov_1 | FP_Cov_2 | PMAQ | PNAUM | VIGITEL | PNS | |||
Diabetes | ||||||||||||||
2007 | 9.3 | 11.2 | 2.3 | – | – | – | – | 5176.04 | 9.3 | 46.1 | – | – | – | – |
2008 | 10.3 | 16.7 | 3.7 | – | – | – | – | 5866.20 | 8.5 | 37.8 | – | – | – | – |
2009 | 10.0 | 17.4 | 3.9 | – | – | – | – | 6765.46 | 8.5 | 38.0 | – | – | – | – |
2010 | 10.4 | 12.9 | 3.2 | – | – | – | – | 6988.75 | 10.3 | 42.0 | – | – | – | – |
2011 | 10.3 | 33.2 | 8.9 | – | – | 16.7 | – | 8348.67 | 4.9 | 18.5 | – | – | 9.8 | – |
2012 | 11.7 | 40.6 | 13.0 | 16.2 | – | 23.1 | – | 9656.00 | 6.0 | 18.7 | 15.0 | – | 10.5 | – |
2013i | 10.9 | 52.9 | 21.2 | – | 18.3 | 24.8 | 57.4 | 11,467.11 | 5.5 | 13.7 | – | 15.8 | 11.7 | 5.1 |
Hypertension | ||||||||||||||
2007 | 35.8 | 6.1 | 1.2 | – | – | – | – | 5176.04 | 42.2 | 205.0 | – | – | – | – |
2008 | 38.4 | 9.7 | 2.4 | – | – | – | – | 5866.20 | 39.2 | 158.7 | – | – | – | – |
2009 | 37.7 | 9.8 | 2.4 | – | – | – | – | 6765.46 | 40.7 | 168.8 | – | – | – | – |
2010 | 36.8 | 7.1 | 1.9 | – | – | – | – | 6988.75 | 43.9 | 166.2 | – | – | – | – |
2011 | 36.8 | 24.3 | 6.0 | – | – | 16.1 | – | 8348.67 | 23.1 | 94.0 | – | – | 37.9 | – |
2012 | 36.8 | 32.6 | 11.5 | 15.3 | – | 22.8 | – | 9656.00 | 25.3 | 72.1 | 54.2 | – | 36.2 | – |
2013i | 36.5 | 39.2 | 15.1 | – | 16.0 | 20.9 | 35.9 | 11,467.11 | 25.1 | 65.2 | – | 61.5 | 47.0 | 27.4 |